CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

Now That There's Agreement to Invest in Innovation, Let's Make it Meaningful

Michelle Woodley, Chief Nursing Informatics Officers and Nancy Yates, Chief Nursing Informatics Officers, Providence St. Joseph Health
Tweet

Healthcare digital innovation has hit a milestone. No longer are executives questioning “if” they should invest. In fact, in a recent study, more than 75 percent of healthcare executives said digital innovation is key to their long-term strategy. The question now is, “How?”


In a period of policy and financial uncertainty, how do we ensure we have the capacity to make necessary investments? And, perhaps most importantly, how do we ensure investments are clearly meaningful assets to our organization and will truly make a difference in the lives of those we touch?


Our responsibility to invest well


All of us in healthcare bear a certain responsibility. Healthcare IT dollars must be spent where it counts: Solving real problems in the healthcare sector. That means we must avoid the projects that simply sparkle yet yield little in true return. We must clearly identify those investments that assure ROI in quality and financial terms, staying true to evidence based medical science and the healing practice of care.


While tempting to implement new patient consumerism technology, the fact remains that only around 7 percent of care is actually “shopable”—as most care is episodic or urgent. However, preventive care technologies and efficiency technologies are being demanded by consumers at an ever increasing rate. We all need to dig deep and meet this challenge.


At our organization, we’ve made digital innovation a top-tier system priority. Our work in this area focuses on key strategies such as wellness and preventive care, improved clinical outcomes, and an enhanced patient and clinician experience. Every initiative must meet milestones and metrics, and contribute to extending our health system’s healing mission.


Sound investments lead the way


Let us give you some examples of what sound and successful digital innovation investments look like for our system. Take telehealth, which can be the eyes and ears of clinicians. Up in Alaska, our Anchorage specialists connect electronically with patients on the remote Unalaska Island to assist with emergencies and develop treatment plans.


Similarly, we have invested in telestroke programs that connect specialists with rural patients who now have access to specialty care they would go without if not for this technology. And one of our favorite telehealth innovations is the NICU Webcam Program, allowing worried parents and loved ones the ability to check in on their precious newborns.


Also important is to make digital innovation meaningful to every day consumers who feel much more empowered when they can participate in their health. 


For example, we’re always improving our online patient portals so patients can access their medical information, pay bills, schedule appointments or message their care provider. With our eVisits and on-demand Express Care suite of services, our patients can access a primary care provider online within minutes from their mobile device or computer to get a common care diagnosis, treatment plan and prescriptions if needed, or book an appointment.


Every initiative must meet milestones and metrics, and contribute to extending our health system’s healing mission


Some innovations can also be behind-the-scenes. For example, we were the first health system to standardize cancer pathology reporting and automate submission to the California Cancer Registry. Working with the College of American Pathology and California Cancer Registry, we were able to dramatically reduce the lag time in reporting cancer staging and facilitate the beginning of what could be a national database for patients to view treatments, locate clinical trials, and become more informed about their health status.


With predictive analytics we are just beginning to use large amounts of demographic, socioeconomic and health-record data to better predict “high risk” and intervene earlier. The pilot to better predict pressure ulcer development is in its very early stages. Sadly, many other industries are well ahead of healthcare in the use of predictive analytics and we have important work to do in this area.


Investing in teams as well as tech


We must remember that even the wisest investments are meant to be tools for our caregivers. No digital miracle, no matter how impressive, can be expected to fully comprehend a medical situation like an experienced clinician. It’s always the clinical expert who—combined with patient input—uses digital innovations as a means to develop and deliver the best treatment path. Better data and technology can help us, but it’s our expertise as clinicians that points the way. And of course, only a living, breathing clinician can offer care and compassion to an individual when it is needed most, remembering care will always be delivered one patient at a time.


That’s why, in addition to investing in innovation, our health system is attentive to the professional growth and formation of our people. We make sure that, along with having the right tools, our caregivers possess the expertise and compassion that are so necessary in healthcare today. We need to remember that this combination of investing in people and technology will always yield the best results.


Weekly Brief

loading
Towards a New World Order
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Value of New Antibiotics in the Fight Against AMR

Piero Rijli, Corporate Director, Regulatory Activities and Market Access, MENARINI Group

Improving Minimal Residual Disease Detection Using NGS

Steven Henck, Ph.D., Vice President of R&D, Integrated DNA Technologies

Multiomic Preclinical Models to Define the Mechanism of Action

Mitch Sanders, Chief Scientific Officer and EVP of the ProDevLab, at Alira Health

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Sanjay Konagurthu, Senior Director, PDS Global Science and Technology, Thermo Fisher Scientific

What the New EMA Draft "Guideline on Computerised Systems and Electronic Data" Means to Your Systems

Cathlin Shapiro, Director, Technology Quality Assurance, Parexel

Pharmaceutical Tablet Coating - Past, Present and Future

Steve Brown, Senior Director EU and APAC Global Manufacturing Science and Technology, Teva Pharmaceuticals [NYSE: TEVA]

Dynamic Commercial Aspects of Life Sciences

Jim Cooper, Director, Clinical Operations, Moderna

Achieving trial master file quality, timeliness and completeness

Susan K. Maue, Designation : Managing Director PharmaLex
Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cxoinsight/now-that-there-s-agreement-to-invest-in-innovation-let-s-make-it-meaningful-nwid-64.html